Pages that link to "Q37908998"
Jump to navigation
Jump to search
The following pages link to Cancer immunotherapy – revisited (Q37908998):
Displaying 50 items.
- Immune checkpoint blockade therapy for bladder cancer treatment (Q26744139) (← links)
- Dendritic-Tumor Fusion Cell-Based Cancer Vaccines (Q26744827) (← links)
- Immunotherapy in Chronic Lymphocytic Leukaemia (CLL) (Q26768154) (← links)
- Bridging academic science and clinical research in the search for novel targeted anti-cancer agents (Q26771396) (← links)
- The Concept of Hormesis in Cancer Therapy - Is Less More? (Q26800519) (← links)
- Biomimetic and synthetic interfaces to tune immune responses (Q26801229) (← links)
- Advances in the understanding of cancer immunotherapy (Q27000706) (← links)
- Trial watch: Dendritic cell-based anticancer therapy (Q27024047) (← links)
- In vivo imaging of therapy-induced anti-cancer immune responses in humans (Q27693338) (← links)
- Nano polymeric carrier fabrication technologies for advanced antitumor therapy (Q28393168) (← links)
- Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity (Q28486600) (← links)
- Epirubicin, Identified Using a Novel Luciferase Reporter Assay for Foxp3 Inhibitors, Inhibits Regulatory T Cell Activity (Q28550203) (← links)
- Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model (Q30276134) (← links)
- Meta-analysis of clinical data using human meiotic genes identifies a novel cohort of highly restricted cancer-specific marker genes. (Q30558949) (← links)
- Immunotherapy in genitourinary malignancies (Q33593800) (← links)
- The translation elongation factor eEF2 is a novel tumor‑associated antigen overexpressed in various types of cancers. (Q33636990) (← links)
- Immunotherapy in head and neck cancer: aiming at EXTREME precision (Q33756244) (← links)
- Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer (Q33873633) (← links)
- Current status of cancer immunotherapy (Q33955720) (← links)
- Neoadjuvant anti-tumor vaccination prior to surgery enhances survival (Q34145877) (← links)
- Chemotherapy enhances cross-presentation of nuclear tumor antigens (Q34226903) (← links)
- The immuno-oncology framework: Enabling a new era of cancer therapy (Q34284462) (← links)
- Human cell-based artificial antigen-presenting cells for cancer immunotherapy (Q34391263) (← links)
- Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8( ) T cells for cancer immunotherapy (Q34429991) (← links)
- 64Cu-DOTA-anti-CTLA-4 mAb enabled PET visualization of CTLA-4 on the T-cell infiltrating tumor tissues (Q34443711) (← links)
- Investigation of CD28 gene polymorphisms in patients with sporadic breast cancer in a Chinese Han population in Northeast China (Q34469269) (← links)
- Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer (Q34527281) (← links)
- Identification of special AT-rich sequence binding protein 1 as a novel tumor antigen recognized by CD8 T cells: implication for cancer immunotherapy (Q34599387) (← links)
- A novel cohort of cancer-testis biomarker genes revealed through meta-analysis of clinical data sets. (Q34781257) (← links)
- Alocasia cucullata exhibits strong antitumor effect in vivo by activating antitumor immunity (Q35005565) (← links)
- Adoptive T cell immunotherapy for cancer. (Q35081485) (← links)
- Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer (Q35144659) (← links)
- Classification of current anticancer immunotherapies (Q35149637) (← links)
- Immunologically augmented skin flap as a novel dendritic cell vaccine against head and neck cancer in a rat model (Q35439353) (← links)
- Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging. (Q35546673) (← links)
- Cytokine-induced killer cells combined with dendritic cells inhibited liver cancer cells (Q35791951) (← links)
- Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations. (Q35869292) (← links)
- Cancer Vaccination Drives Nanog-Dependent Evolution of Tumor Cells toward an Immune-Resistant and Stem-like Phenotype (Q35871717) (← links)
- Identification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies (Q35897592) (← links)
- Programmed death ligand 2 in cancer-induced immune suppression. (Q35955151) (← links)
- Phase I/II study of adjuvant immunotherapy with sentinel lymph node T lymphocytes in patients with colorectal cancer (Q35968018) (← links)
- Dynamic treatment effect (DTE) curves reveal the mode of action for standard and experimental cancer therapies (Q35987437) (← links)
- γ-H2AX and other histone post-translational modifications in the clinic (Q36019818) (← links)
- Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients (Q36060333) (← links)
- Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens (Q36112645) (← links)
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer (Q36228550) (← links)
- Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients (Q36247439) (← links)
- Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates (Q36370196) (← links)
- SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccines (Q36487245) (← links)
- A novel method for evaluating antibody-dependent cell-mediated cytotoxicity by flowcytometry using cryopreserved human peripheral blood mononuclear cells (Q36506949) (← links)